143 related articles for article (PubMed ID: 23535962)
21. Brain metastases in patient with prostate cancer found in 18F-choline PET/CT.
Gizewska A; Witkowska-Patena E; Stembrowicz-Nowakowska Z; Buraczewska A; Dziuk M
Nucl Med Rev Cent East Eur; 2015; 18(1):39-41. PubMed ID: 25633517
[TBL] [Abstract][Full Text] [Related]
22. Supraclavicular metastasis in prostate cancer detected with 18F-fluorocholine PET/CT.
Núñez Miller R; Viera JC; Jover Díaz R; Rojo Sebastián A; Pozo MA; Alfonso Alfonso JM
Rev Esp Med Nucl Imagen Mol; 2012; 31(1):44-6. PubMed ID: 21719158
[No Abstract] [Full Text] [Related]
23. Cancer imaging with fluorine-18-labeled choline derivatives.
Kwee SA; DeGrado TR; Talbot JN; Gutman F; Coel MN
Semin Nucl Med; 2007 Nov; 37(6):420-8. PubMed ID: 17920349
[TBL] [Abstract][Full Text] [Related]
24. Incidental pituitary adenoma detected by
Albano D; Bosio G; Bertagna F
Rev Esp Med Nucl Imagen Mol (Engl Ed); 2018; 37(4):250-252. PubMed ID: 28800881
[No Abstract] [Full Text] [Related]
25. [Pitfalls with 18F-choline PET/CT in patients with prostate cancer].
García Vicente AM; Núñez García A; Soriano Castrejón AM; Jiménez Londoño GA; Cordero García JM; Palomar Muñoz A
Rev Esp Med Nucl Imagen Mol; 2013 Jan; 32(1):37-9. PubMed ID: 23177342
[TBL] [Abstract][Full Text] [Related]
26. Effect of erythropoietin on bone marrow uptake of 18F-fluorocholine in prostate cancer: comparison with 18F-fluoride uptake.
Balogova S; Huchet V; Egrot C; Michaud L; Paycha F; Kerrou K; Montravers F; Cussenot O; Talbot JN
Clin Nucl Med; 2013 Mar; 38(3):200-2. PubMed ID: 23354033
[TBL] [Abstract][Full Text] [Related]
27. Evaluation of treatment response using integrated 18F-labeled choline positron emission tomography/magnetic resonance imaging in adolescents with intracranial non-germinomatous germ cell tumours.
Tsouana E; Stoneham S; Fersht N; Kitchen N; Gaze M; Bomanji J; Fraioli F; Hargrave D; Shankar A
Pediatr Blood Cancer; 2015 Sep; 62(9):1661-3. PubMed ID: 25854508
[TBL] [Abstract][Full Text] [Related]
28. 18F NaF brain metastasis uptake in a patient with melanoma.
Jones RP; Iagaru A
Clin Nucl Med; 2014 Oct; 39(10):e448-50. PubMed ID: 24566410
[TBL] [Abstract][Full Text] [Related]
29. A thyroid incidentaloma detected by 18F-choline PET/CT.
Treglia G; Giovannini E; Mirk P; Di Franco D; Oragano L; Bertagna F
Clin Nucl Med; 2014 Apr; 39(4):e267-9. PubMed ID: 23579984
[TBL] [Abstract][Full Text] [Related]
30. Comparison of [18 F]fluorocholine and [18 F]fluorodeoxyglucose for positron emission tomography of androgen dependent and androgen independent prostate cancer.
Price DT; Coleman RE; Liao RP; Robertson CN; Polascik TJ; DeGrado TR
J Urol; 2002 Jul; 168(1):273-80. PubMed ID: 12050555
[TBL] [Abstract][Full Text] [Related]
31. Incidental possible diagnosis by 18F-fluorocholine PET/CT of Meckel's diverticulum and potential pitfalls.
Khor LK; Loi HY; Sinha AK; Lu SJ
Hell J Nucl Med; 2015; 18(2):157-9. PubMed ID: 26187217
[TBL] [Abstract][Full Text] [Related]
32. Distribution patterns of 18F-labelled fluoromethylcholine in normal structures and tumors of the head: a PET/MRI evaluation.
Mertens K; Ham H; Deblaere K; Kalala JP; Van den Broecke C; Slaets D; De Vos F; Goethals I
Clin Nucl Med; 2012 Aug; 37(8):e196-203. PubMed ID: 22785527
[TBL] [Abstract][Full Text] [Related]
33. A pilot comparison of 18F-fluorodeoxyglucose and 18F-fluorocholine PET/CT to predict early recurrence of unifocal hepatocellular carcinoma after surgical resection.
Fartoux L; Balogova S; Nataf V; Kerrou K; Huchet V; Rosmorduc O; Talbot JN
Nucl Med Commun; 2012 Jul; 33(7):757-65. PubMed ID: 22504293
[TBL] [Abstract][Full Text] [Related]
34. Solitary brain lesions enhancing at MR imaging: evaluation with fluorine 18 fluorocholine PET.
Kwee SA; Ko JP; Jiang CS; Watters MR; Coel MN
Radiology; 2007 Aug; 244(2):557-65. PubMed ID: 17581887
[TBL] [Abstract][Full Text] [Related]
35. Assessment of combination of contrast-enhanced magnetic resonance imaging and positron emission tomography/computed tomography for evaluation of ovarian masses.
Tsuboyama T; Tatsumi M; Onishi H; Nakamoto A; Kim T; Hori M; Sakane M; Hori Y; Morii E; Hatazawa J; Tomiyama N
Invest Radiol; 2014 Aug; 49(8):524-31. PubMed ID: 24637584
[TBL] [Abstract][Full Text] [Related]
36. Pseudo-subarachnoid hemorrhage and cortical visual impairment as the presenting sign of gliomatosis cerebri.
Belsare G; Lee AG; Maley J; Kirby P; St Louis EK; Follett K
Semin Ophthalmol; 2004; 19(3-4):78-80. PubMed ID: 15590541
[TBL] [Abstract][Full Text] [Related]
37. Synthesis and evaluation of (18)F-labeled choline analogs as oncologic PET tracers.
DeGrado TR; Baldwin SW; Wang S; Orr MD; Liao RP; Friedman HS; Reiman R; Price DT; Coleman RE
J Nucl Med; 2001 Dec; 42(12):1805-14. PubMed ID: 11752077
[TBL] [Abstract][Full Text] [Related]
38. FuMeGA Criteria for Visual Assessment of Postoperative 18F-Fluorocholine PET in Patients With Glioma.
García Vicente AM; Pena Pardo FJ; Lozano Setien E; Sandoval Valencia H; Villena Martín M
Clin Nucl Med; 2020 Jun; 45(6):448-450. PubMed ID: 32349093
[TBL] [Abstract][Full Text] [Related]
39. Asymmetric muscle activity on (18)F-FDG PET/CT.
Palard X; Carai S; Le Roux PY; Salaün PY; Abgral R
Clin Nucl Med; 2015 Jun; 40(6):e336-7. PubMed ID: 25706792
[TBL] [Abstract][Full Text] [Related]
40. Fluorocholine (18F) and sodium fluoride (18F) PET/CT in the detection of prostate cancer: prospective comparison of diagnostic performance determined by masked reading.
Langsteger W; Balogova S; Huchet V; Beheshti M; Paycha F; Egrot C; Janetschek G; Loidl W; Nataf V; Kerrou K; Pascal O; Cussenot O; Talbot JN
Q J Nucl Med Mol Imaging; 2011 Aug; 55(4):448-57. PubMed ID: 21738117
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
